Floatz logo

Bm-Mnc

Erectile Dysfunction

Chinese Academy of SciencesCell therapyPhase 1/2Dormant
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
81/ 100

Competitive context

18 Active assets in the Erectile Dysfunction cohort.

Asset / SponsorPhaseRating
Tadalafil
Surgical Outcomes Research Centre (SOuRCe)
Phase 4BB
Sildenafil
The Netherlands Cancer Institute
Phase 4BB
Ningmitai
Xintian Pharmaceutical
Phase 4BB
BAY38-9456
Bayer
Phase 4BB
Vardenafil
Medical University of Vienna
Phase 4BB

View all 33 →

Same molecule, other indications

Bm-Mnc is also rated in:

disease related to hematopoietic stem cell transplantDormant
CCC
Indicative ·
50 / 100
View asset →
cirrhosis of liverDormant
CC
Indicative ·
46 / 100
View asset →
Rectal CancerDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →